hotspot -WSS

hotspot

author：fashion 2025-10-02 22:41:24 - browse：2

IQVIA signage. -- health tech coverage from STAT — Adobe

The health data giant IQVIA became a dominant force by gobbling up its rivals. Over decades, it feasted on upstarts with new datasets or novel technologies, growing into a juggernaut with no peer in the business of brokering Americans’ medical information.

Now, government regulators say, IQVIA’s appetite for acquisition is getting out of control — and must be reined in.

A Federal Trade Commission lawsuit seeking to block its acquisition of the digital advertising firm DeepIntent marks a crossroads for the company and the multi-billion dollar medical advertising economy it serves. The agency, which is seeking an injunction and temporary restraining order in federal court, argues that IQVIA’s data vault has become so large — and revealing — that it forms the substrate of an entire industry focused on showering doctors and patients with marketing messages.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Mitch McConnell episode has important public health takeaway

WSS

NIH launches clinical trials and new research office for long Covid

Lawsuit alleges UnitedHealth Group unit illegally denied claims

Analysis of telehealth claims data suggest service duplication

The high personal cost of affirmative action for Black doctors

Stroke deaths set to near 10 million globally by 2050

Liquid biopsy for lung cancer is launched by Delfi

leisure time

hotspot

hotspot

Malaria cases in Florida and Texas: Here’s what you need to know

Phenylephrine and the overlooked value of the placebo effect

United colonoscopy coverage change 'may cost lives,' doctors say

When women are denied an abortion, their children fare worse than peers

Sports medicine is finally prioritizing gender equality

Breakthrough Alzheimer’s drugs are inaccessible in rural states

Malaria cases in Florida and Texas: Here’s what you need to know

AI can decode, harness the power of the humane immune system

FDA approval of Sarepta Duchenne genetic therapy gives me hope

A Q&A with the global head of Boehringer Ingelheim's innovation unit

hotspot

NIH launches clinical trials and new research office for long Covid

Bristol 'take

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

FDA rejects Alnylam's heart disease treatment over insufficient data

National panel will explore requiring free Covid tests

The future of health care in the House

focus

explore

focus

Wikipedia